ASTRAZENECA GLUCOSE 10% w/v 1g/10mL injection BP ampoule

Land: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Kauptu það núna

Download Opinber matsskýrsla (PAR)
02-12-2017

Virkt innihaldsefni:

glucose, Quantity: 100 mg/mL

Fáanlegur frá:

Phebra Pty Ltd

INN (Alþjóðlegt nafn):

glucose

Lyfjaform:

Injection, solution

Samsetning:

Excipient Ingredients: sodium bicarbonate; water for injections

Stjórnsýsluleið:

Intravenous

Einingar í pakka:

10mL x 50

Gerð lyfseðils:

Not scheduled. Not considered by committee

Ábendingar:

This product accepted for registration/listing as 'currently supplied' at the time of commencement of the Act. Indications held in ARTG paper records. (Old code) INDICATIONS AS AT 12 AUGUST 2003: Glucose Injection BP 10% is used in the treatment of carbohydrate and fluid depletion. Glucose is the preferred source of carbohydrate in parenteral nutrition regimes, and is used in the treatment of dehydration due to acute diarrhoeal disease. Glucose Injection BP 10% is used in preference to the 5% solution to provide adequate calories in a minimal volume of water and Glucose Injection BP 10% may also be used to treat hypoglycaemia.

Vörulýsing:

Visual Identification: Clear colourless particle-free solution; Container Type: Ampoule; Container Material: Glass; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Leyfisstaða:

Registered

Leyfisdagur:

1991-08-13